$MRNA News

Moderna (MRNA) Registers a Bigger Fall Than the Market: Important Facts to Note

Stock Market Today: Dow Ends Higher; SK Hynix Jumps In U.S. Trading Debut; Moderna Tumbles

MRNA Stock Eyes Worst Week In 11 Months After June Surge — What’s Ahead?

Why Moderna (MRNA) Stock Is Trading Up Today

Moderna (MRNA) Stock May Sit Above Fair Value Following Pipeline Expansion

Moderna secures up to 24 million RSV vaccine dose contract with Europe

Moderna to Report Second Quarter 2026 Financial Results on Friday, July 31, 2026

RBC Capital Raises its Price Target on Moderna (MRNA)

Morgan Stanley Maintains Equal-Weight on Moderna, Raises Price Target to $39

ABUS Stock Rallies Ahead Of Big Payout From Moderna Settlement This Week

RBC Capital Maintains Sector Perform on Moderna, Raises Price Target to $45

B of A Securities Maintains Underperform on Moderna, Raises Price Target to $38

Moderna (MRNA) Outpaces Stock Market Gains: What You Should Know

Jim Cramer turns bullish on health care stock after years of doubt

I'm excited about Moderna's turn but it's had a huge run: Jim Cramer

Short Squeeze Alert—Moderna Stock Surges on New Strategy

MRNA Stock Spikes as Moderna Shares mRNA Pipeline Update

Stock Of The Day: Will The Moderna Rally Continue?

This COVID Stock Market Winner Is Making a Comeback, Up 125% Year to Date

MRNA Stock Rallies Over 40% In June: Moderna Bets Its Future On Cancer, Autoimmune Disease And AI-Powered mRNA